Sage PT, Ron-Harel N, Juneja VR, et al. Suppression by TFR cells leads to durable and selective inhibition of B cell effector function. Nat Immunol. 2016;17(12):1436-1446. doi:10.1038/ni.3578
Publications
Muñoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol. 2016;16(12):741-750. doi:10.1038/nri.2016.99
Chen BH, Hivert MF, Peters MJ, et al. Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations. Diabetes. 2016;65(12):3794-3804. doi:10.2337/db16-0470
Jungreis I, Chan CS, Waterhouse RM, Fields G, Lin MF, Kellis M. Evolutionary Dynamics of Abundant Stop Codon Readthrough. Mol Biol Evol. 2016;33(12):3108-3132. doi:10.1093/molbev/msw189
Nielson CM, Liu CT, Smith AV, et al. Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2. J Bone Miner Res. 2016;31(12):2085-2097. doi:10.1002/jbmr.2913
Skoglund P, Reich D. A genomic view of the peopling of the Americas. Curr Opin Genet Dev. 2016;41:27-35. doi:10.1016/j.gde.2016.06.016
Sips M, Liu Q, Draghi M, et al. HLA-C levels impact natural killer cell subset distribution and function. Hum Immunol. 2016;77(12):1147-1153. doi:10.1016/j.humimm.2016.08.004
Taylor-Weiner A, Zack T, O’Donnell E, et al. Genomic evolution and chemoresistance in germ-cell tumours. Nature. 2016;540(7631):114-118. doi:10.1038/nature20596
Morgan EA, Sweeney P, Tomoka T, et al. Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities. Blood Adv. 2016;1(1):84-92. doi:10.1182/bloodadvances.2016000026
Hill SJ, Mordes DA, Cameron LA, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci U S A. 2016;113(48):E7701-E7709. doi:10.1073/pnas.1611673113